All regulations
Nonrulemaking
FDA
Open for Comments
FDA-1996-D-0048
Impurities in New Drug Products Guideline
Documents
6
Comments
2
Description
Docket Status: OPEN Remarks: ALLEN RUDMAN/GUIDLIE
Key Dates
Comment Period OpensJul 19, 2000
Comment Period ClosesSep 19, 2000
Documents
| Type | Title | Status |
|---|---|---|
Other |
Comment Statistics
Total Comments
2
Keywords
Q3B(R)
SUBSTANCES
IMPURITIES
PRODUCTS
CHEMICALLY
SYNTHESIZED
NEW DRUG
HUMAN USE
ICH
Data from Regulations.gov